Rectal cancer lateral pelvic sidewall lymph nodes: a review of controversies and management

JS Williamson, AJ Quyn, PM Sagar - Journal of British Surgery, 2020 - academic.oup.com
Background The management of lateral pelvic lymphadenopathy in low rectal cancer poses
an oncological and technical challenge. Interpretation of the literature is confounded by …

[HTML][HTML] Lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer: a single-center experience and literature review

MC Kim, JH Oh - Annals of Coloproctology, 2021 - ncbi.nlm.nih.gov
Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …

Radiomics approach outperforms diameter criteria for predicting pathological lateral lymph node metastasis after neoadjuvant (chemo) radiotherapy in advanced low …

R Nakanishi, T Akiyoshi, S Toda, Y Murakami… - Annals of surgical …, 2020 - Springer
Background Advanced low rectal cancer has a non-negligible risk of lateral pelvic lymph
node (LPLN) metastasis (LPLNM) and lateral local recurrence (LR) after neoadjuvant …

Magnetic resonance imaging directed surgical decision making for lateral pelvic lymph node dissection in rectal cancer after total neoadjuvant therapy (TNT)

O Peacock, N Manisundaram, SR Dibrito, Y Kim… - Annals of …, 2022 - journals.lww.com
Objective: Lateral pelvic lymph node (LPLN) metastases are an important cause of
preventable local failure in rectal cancer. The aim of this study was to evaluate clinical and …

The landmark series: management of lateral lymph nodes in locally advanced rectal cancer

O Peacock, GJ Chang - Annals of surgical oncology, 2020 - Springer
There has historically been a significant divide in the approach to the management of lateral
pelvic lymph nodes in patients with rectal cancer. These differing paradigms have …

Systematic review and meta-analysis of long-term oncological outcomes of lateral lymph node dissection for metastatic nodes after neoadjuvant chemoradiotherapy in …

HM Kroon, LA Hoogervorst, N Hanna-Rivero… - European Journal of …, 2022 - Elsevier
Abstract Background Standard Western management of rectal cancers with pre-treatment
metastatic lateral lymph nodes (LLNs) is neoadjuvant (chemo) radiotherapy (nCRT) followed …

[HTML][HTML] Lateral lymph node dissection in rectal cancer: state of the art review

SJA Hazen, TC Sluckin, T Konishi, M Kusters - European Journal of …, 2022 - Elsevier
Half of the local regional recurrences from rectal cancer are nowadays located in the lateral
compartments, most likely due to lateral lymph node (LLN) metastases. There is evidence …

Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo) radiotherapy: an international …

HM Kroon, S Malakorn, NN Dudi-Venkata… - European Journal of …, 2021 - Elsevier
Abstract Background In the West, low rectal cancer patients with abnormal lateral lymph
nodes (LLNs) are commonly treated with neoadjuvant (chemo) radiotherapy (nCRT) …

[HTML][HTML] Lateral lymph nodes in rectal cancer: Do we all think the same? A review of multidisciplinary obstacles and treatment recommendations

TC Sluckin, AM Couwenberg, DMJ Lambregts… - Clinical Colorectal …, 2022 - Elsevier
Lateral lymph nodes in low, locally advanced, rectal cancer have proven implications for
local recurrence rates, which increase drastically in the presence of persistently enlarged …

Management of lateral pelvic lymph nodes in rectal cancer

G Chang, WJ Halabi, F Ali - Journal of Surgical Oncology, 2023 - Wiley Online Library
Lateral pelvic lymph node (LPLN) involvement occurs in 10%–25% of rectal cancer cases.
Total mesorectal excision (TME) with routine LPLN dissection (LPLND) is predominantly …